- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Your New Therapist: Chatty, Leaky, and Hardly Human
- Listen: With Little Federal Regulation, States Are Left To Shape the Rules on AI in Health Care
- BIO comes out swinging with 'Fight of Our Lives' campaign for the industry’s 50th birthday
- The recent evolution of anesthesia strategy
- The future of medical-dental integration is here
- Trinity Health to open $226M replacement hospital April 19
- Sharp HealthCare taps Apple Vision Pro for surgical innovation
- The law that could help fix anesthesia reimbursement issues — and why it’s being ignored
- UW Health inks deal to become Packers’ official healthcare partner
- California hospital CEO steps down
- How CHS, HCA, Tenet, and UHS’ CEO-to-worker pay ratios ranked in 2025
- Texas dentist has license suspended
- RFK Jr. says he’ll reform preventive task force: 4 hearing takeaways
- 10 fastest-growing jobs for new graduates
- Northwestern Medicine posts 4.5% operating margin in Q2
- Rotavirus cases increase across US
- Tenet’s 5 highest-paid execs in 2025
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- Stereotaxis to acquire cardiovascular robotics company for $45M
- Meritus Health adds Dr. Christine Lewis
- What’s the deal with insurer mental health parity violations?
- NYU Langone Health opens 12K-square-foot ambulatory location
- 10 anesthesia leadership appointments from Q1
- What could improve physician market competition
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- How ESOPs can help retiring physicians cash out
- Specialty1 Partners’ growth in 2026: 5 updates
- UnityPoint Health to transition dental services to FQHC
- The ownership opportunity ASCs are leaving behind
- New York hospital taps ambulatory operations leader
- Verily Health simplifies medical jargon alphabet soup with AI-powered app in new campaign
- 10 trends in behavioral health usage: Report
- 4 DSOs adding new technology
- Aspen Dental opens Michigan office
- Studies reaffirm fluoride safety, benefits: 10 things to know
- New Oklahoma law closes dental insurer price fixing loophole
- Cattywampus: Statement on the CAT Concept Release
- Providers' advantage on out-of-network billing disputes likely to continue: Capstone
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- Kentucky approves changes to Dental Practice Act
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- EPA Delays Decisions on 'Forever Chemicals'
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- ‘Mini specialists’: 5 models reshaping behavioral health in primary care
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- Progyny unveils new fertility benefit option for small, mid-size employers
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Chicago hospital expands outpatient, walk-in mental health services
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- Hospitals with more disadvantaged patients fall short on price transparency, study finds
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Bill would force payers to apply DTC drug purchases to patient deductibles
- 43 states have mental health insurance disparities: 4 trends
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- Listen to the Latest ‘KFF Health News Minute’
- The new playbook for clinician well-being
- Estados cambian leyes para evitar que hijos de inmigrantes detenidos entren al sistema de cuidado temporal
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- Cómo hacer que un plan de salud con deducible alto funcione para tí
- Anthem, Mount Sinai reach contract agreement, restore in-network coverage
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Stanford Health Care, Alameda Health System partner to support St. Rose Hospital
- Para muchos pacientes que salen de terapia intensiva, la lucha apenas comienza
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Does Your Child Have Nightmares? Here's One Solution
- Marriage's Hidden Benefit? A Lower Risk Of Cancer
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- WebMD Ignite rolls out program to help providers get Rural Health Transformation efforts off the ground
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- NewYork-Presbyterian to enact behavioral health reforms, pay $500K in wake of investigation
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- New Rules May Allow Broader Picks for CDC Vaccine Panel
- Second Meningitis Vaccine Doses Offered After U.K. Outbreak
- Crackdown on Vapes Falling Short, Report Finds
- Jasmine Rice Recalled Nationwide Over Possible Contamination
- ‘The next opioid epidemic’: Gambling legalization outpaces public health response to addiction
- Thinking About A GLP-1 Drug? Your Genetics Might Determine How Well You'll Fare
- Fighting High Blood Pressure? Having A Team On Your Side Can Help
- Radon Gas Increases Risk Of Ovarian Cancer, Study Says
- Your Doctor Might Be Using The Wrong Test To Track Your Cholesterol, Study Says
- Losing Teeth May Lead to Weight Gain, Researchers Report
- Heart Risk Worse With Sleep Apnea That Varies Night-By-Night
- Lilly’s Jaypirca shows fixed-duration power in ‘ambitious’ phase 3 CLL trial win
- ViiV launches ‘Still Here’ campaign aimed at reminding young people about HIV
- Statement Regarding Staff No-Action Letter to Bank of England
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
No one seems happy with President Trump’s actions to expand access to in vitro fertilization (IVF):
https://thehill.com/policy/healthcare/5561456-trump-ivf-action-mixed-reactions/
Trump’s IVF moves: ‘Huge leap’ or ‘broken promises’?
By Joseph Choi - October 18, 2025President Trump’s dual-pronged action on expanding access to in vitro fertilization (IVF) is garnering mixed reactions from lawmakers, advocates and medical groups, with some calling it a step in the right direction, if only to start the conversation.
Speaking from the Oval Office on Thursday, Trump announced new federal guidance on insurance coverage for IVF services, as well as his administration’s latest deal with a drug manufacturer under his “most favored nation” pricing policy.
The updated guidance from the Department of Labor, the Treasury Department and the Department of Health and Human Services (HHS) would make opting in to fertility benefits similar to opting in for dental or vision benefits as part of an employer’s insurance plan.
EMD Serono, the manufacturer of commonly used infertility treatments like Gonal-F, announced it would be offering its “leading IVF therapies” at steep discounts. The company said in a press release that the agreement came with an exemption from Section 232 tariffs that the White House had threatened against pharmaceutical companies.
On the campaign trail, Trump — who called himself the “father of IVF” on Thursday — had vowed to make IVF available to everyone, either by the government funding it or by requiring insurers to cover it. The initiatives announced Thursday resemble neither of these plans.
Still, the announcement was well-received by some groups championing fertility services.
Moshe Margaretten, founder and president of Americans for IVF, called it a “huge leap forward in the fight to make fertility care affordable and accessible.”
“But as meaningful as this step is, we know our work is not finished. Indeed, the president said today that this is just the beginning,” Margaretten said. “We will continue working with the White House and Congress, advocating for further reforms until every family struggling with infertility can find the support and opportunity they deserve.”
Alabama Sen. Katie Britt (R) called the announcement the “most pro-IVF thing that any president in the history of the United States of America has done.”
Sean Tipton, chief advocacy and policy officer of the American Society for Reproductive Medicine, agreed with Britt’s assessment.
“But I think that indicates what a tremendously low bar that is. Because these policy announcements are not going to accomplish what the president said he wanted to accomplish, that is to make IVF available to everybody,” Tipton said.
He agreed that finances are a significant barrier to accessing IVF services, particularly in the U.S., but he wasn’t entirely sold on the plan requesting that employers consider covering fertility services for their employees.
“There are no sticks here. It’s all moderate carrots,” he said.
While acknowledging that a presidential endorsement of IVF coverage could go a long way, Tipton said this policy was “not nearly as valuable as a law,” and it’s unclear how many companies would actually be willing to cover the very costly procedure, with an IVF cycle costing between $15,000 and $20,000.
A reduction in the cost of Gonal-F is still significant, however, as the drug component of a cycle can cost between $5,000 and $6,000.
Sen. Elizabeth Warren (D-Mass.) blasted the nature of the policy, given that Congress is locked in a fight over ensuring continued health care coverage.
“It’s clear that Donald Trump lied when he told the American people he’d make IVF available to every family for free,” Warren said immediately after the announcement.
“Instead, Trump’s new genius plan is to rip away Americans’ health insurance and gut the CDC’s IVF team, then politely ask companies to add IVF coverage out of the goodness of their own hearts — with zero federal investment and no requirement for them to follow through. It’s insulting, and yet another one of Trump’s broken promises to American families,” she added.
Pushback from anti-abortion voices was also anticipated, given that unused embryos are regularly discarded or donated in the IVF process. Trump was asked about this anticipated criticism, which he dismissed by saying, “You can’t get more pro-life than this.”
“Any policy in this space, from the White House or Congress, must treat the lives of the smallest children in the highest regard,” Marjorie Dannenfelser, president of the anti-abortion group Susan B. Anthony Pro-Life America, said in a statement, reiterating her organization’s stance that “human embryos should not be destroyed.”
“We support focusing on restorative fertility treatments to help couples struggling with infertility, and urge high ethical and medical standards for the IVF industry,” she added. “Too often, the IVF industry is given blanket immunity — despite growing numbers of horror stories like rogue practitioners switching embryos, ignoring basic safety standards, or negligently destroying embryos.”
Granting embryos personhood was at the core of the lawsuit that pushed IVF into the national conversation last year when the Supreme Court of Alabama ruled that frozen embryos could be considered the same as children. This temporarily put IVF services in the state on pause, with clinics apprehensive of risking legal action.
Republican lawmakers found themselves in a uniquely difficult position: They concurred with the court’s findings while also being reticent to support blocking IVF services. Democrats, in turn, cited the ruling as an escalation of the overturning of Roe v. Wade, placing blame on Trump for nominating Supreme Court justices who helped overturn the landmark ruling.
EMILY’s List, a major Democratic group that backs female Democratic candidates who support abortion access, called it “another sorry proposal” from Trump.
“While Republicans pretend to care about women, they’re actively working to strip millions of women of their health insurance and push essential health care out of reach,” EMILY’s List President Jessica Mackler said. “Making IVF more accessible and affordable is going to rely on securing Democratic power by taking back Congress and electing women leaders across states who will deliver real solutions for these families.”
Negative story on proposed IVF changes from States Newsroom:
Trump’s IVF announcement disappoints patients, raises concerns for doctor
By Kelcie Moseley-Morris - October 21, 2025Miraya Gran is the kind of person who Republican President Donald Trump and his administration say they are going to help with new policies on in vitro fertilization.
It took a second mortgage on her Minnesota house and a family fundraiser to afford the IVF treatment she needed to have her first child in 2021. Gran’s husband has male-factor infertility, and she has a genetic blood disorder, making it extremely difficult for them to conceive on their own. But unless the cost of IVF goes down a lot, Gran can’t afford to give her daughter a sibling.
“I’ve got two embryos waiting for me, and I’m not accessing them due to lack of insurance coverage,” she said.
But Gran doesn’t have much hope left that IVF costs will drop enough after Trump’s announcement at the White House on Thursday, Oct. 16. The president said his administration negotiated steep discounts on a key fertility drug, as well as a new regulation allowing employers to offer IVF coverage as a standalone policy like dental or vision. EMD Serono, a major pharmaceutical brand, will offer the medication at an 84% discount via direct sales on a government webpage called TrumpRX, according to a company representative who spoke at the White House event.
Gran said that isn’t good enough. The drug prices are only a portion of what makes treatment expensive. One IVF cycle ranges between $12,000 and $25,000 on average but can cost more depending on medical needs. Many people require more than one round of IVF to get pregnant.
Plus, the new policy only clears the way for employers to offer coverage options — it’s not required by the government.
“They have the ability to put the onus on insurance companies,” Gran said. “There really isn’t a solution for our community until we have insurance coverage.”
Trump campaigned on a promise to make IVF treatment free for all, either through federal funding or insurance, but has so far not fulfilled that promise.
Dr. Eve Feinberg is an OB-GYN professor at Northwestern University, and a reproductive endocrinologist and fertility specialist who treats IVF patients every day. She said lowering the cost of the drugs is a positive step, but that’s only about one-third of the cost of a typical IVF cycle — less in some cases.
“For some patients, the medications can go as high as half the cost,” Feinberg said. “If you have a good reserve of eggs, you require less medication. If you have a lower reserve, you’ll need more. So for some, it’s $3,000 … and for some, it’s $10,000.”
‘Restorative reproductive medicine’ not a replacement for IVF, doctor says
Trump’s promise to make IVF free is a difficult one to fulfill not only because of the overall cost but because of divisions among conservative groups about the ethics of the treatment. IVF requires the collection of as many eggs as possible that are then fertilized. Some are later destroyed because they would not make it after implantation in the uterus due to abnormalities or other medical factors.
The Alabama Supreme Court ruled in 2024 that embryos have the same legal rights as children, which threw the medical community into chaos and caused some Alabama IVF clinics to close. Later that year, the Southern Baptist Convention adopted an anti-IVF resolution stating the church’s opposition to the practice.
The ruling happened just as Latorya Beasley was waiting on a transfer date for the embryo she hoped would be her second child. Her clinic temporarily canceled appointments but eventually reopened, and she was able to have a second child. Beasley had IVF insurance through her employer, which only about 25% of companies with more than 200 employees offer nationwide, according to KFF. But there were still out-of-pocket costs.
“There was a point where we ran out of medicine for like one day, and we paid $1,000 out of pocket for that,” Beasley said. “And that was with insurance coverage.”
Feinberg said she was also worried about the aspects of the announcement that talked about “restorative reproductive medicine,” which is a newer field of medicine not recognized by the same medical boards guiding reproductive endocrinology. The practice has been promoted by the Heritage Foundation — a conservative advocacy organization that authored Project 2025 — as the “new frontier” of reproductive medicine.
“There were certain things said in the briefing that made me think the idea of fertility coverage, especially for companies whose beliefs and ideas are religiously focused and religiously based, that may mean offering restorative reproductive medicine and not offering IVF,” she said.
The restorative practice focuses on cycle tracking to conceive, as well as weight loss and nutrition. Feinberg said she had a patient who had been using those methods for four years with no success, and she was 43 by the time a reproductive specialist told her that her husband had such a low sperm count, there was no way they could conceive without medical intervention.
“He had a genetic mutation that the restorative reproductive medicine person was not trained to ever diagnose,” she said. “They could have and should have done IVF.”
Gran and Beasley said if the Trump administration put forward plans that made a real difference for families in need of IVF, they would be the first to celebrate it. But until then, the lack of action is frustrating.
“It just feels like I’m being sold a complete line from a traveling salesman, because until there’s actual substantiated change, I have no faith in what they say,” Gran said.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















